AKCEA-APO(a)-LRx Advances as Leading Pharmaceutical Company Exercises Option to License

NEXT STORY
FIT Biotech Oy: The Board of Directors of FIT Biotech Oy has decided to file for bankruptcy
PREV STORY
Roche enters into definitive merger agreement to acquire Spark Therapeutics
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Health in Code’s Novel Work Published In JACC, Helps Increase Sensitivity Detection for Admera Health’s CardioGxOne™ Test Regarding Patients with High-Risk Dilated and Arrhythmogenic Cardiomyopathies

A CORUÑA, Spain and SOUTH PLAINFIELD, N.J., May 03, 2017 (GLOBE NEWSWIRE) -- Today, ...

author_avatar
NASDAQ Market News

CrownBio’s Translatable FATZO Model Utilized in Eli Lilly’s Preclinical Type 2 Diabetes Research Programs

SANTA CLARA, Calif., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary ...

author_avatar
NASDAQ Market News

Preclinical Research on the Role of Galectin-3 in Pulmonary Arterial Hypertension to be Presented at the American Thoracic Society 2016 International Conference

NORCROSS, Ga., May 05, 2016 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ:GALT), the leading ...

author_avatar
NASDAQ Market News